Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14

Deprecated: Function jetpack_form_register_pattern is deprecated since version jetpack-13.4! Use Automattic\Jetpack\Forms\ContactForm\Util::register_pattern instead. in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 6078
Research & Development (R&D) Archives - The Pharma Times | Pharma & Health Care News Portal

Research & Development (R&D)

Genetic Diseases to be Detected in Fetus; State-of-the-art Technology at Sabine Hospital, Kerala

Kochi, February 08, 2024: Sabine Hospital, a Kerala based IVF hospital is all set to install a state-of-the-art machine which…

3 months ago

Genetic Testing Brand Progenesis Enters the Indian Market

New Delhi, December 12,  2023 :  Progenesis, a globally renowned genetic testing brand based in the USA, has officially stepped…

5 months ago

Rainbow Children’s Hospital Launches a Dedicated Paediatric Constipation Clinic in Marathahalli

Bangalore, August 21, 2023:  Rainbow Children's Hospital, Marathahalli is excited to announce the opening of its new Paediatric Constipation Clinic.…

9 months ago

Ikris Pharma takes strides against breast cancer with the inspiring Ikris Run; uniting communities for awareness and action

Noida, August 19, 2023: With an unwavering commitment to raising awareness and driving meaningful action, Ikris Pharma has announced the highly…

9 months ago

Kerala Ayurveda Limited receives US patent for its herbal formulation

 The United States Patent and Trademark Office (USPTO) has granted KAL its first patent for a proprietary herbal formulation that…

1 year ago

Sputnik V vaccine granted full permanent approval in Russia

Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries…

2 years ago

Leading Pulmonologists in India have started using Molnupiravir for mild COVID-19 cases; consider it the best bet for early treatment of COVID-19.

Mumbai, January 26, 2022: With questions being raised on the safety of the only available approved oral antiviral pill for COVID-19…

2 years ago

Biophore receives sub-license from MPP to manufacture and market molnupiravir for COVID treatment

Can market in India and 104 other countries Has also received DCGI regulatory license for Indian market Licenses applicable for…

2 years ago

LumiraDx Receives Approval for its COVID-19 Antigen Test for use in India

London, October 30, 2021:  Test combines sensitivity with speed and is designed to be used in health care settings to…

3 years ago

Cipla gets USFDA nod for inhalation product

Drug major Cipla NSE 0.65 % on Wednesday said it has received final approval from the US health regulator for Arformoterol Tartrate…

3 years ago